Analyst Price Targets — AVAH
| Date | Analyst | Firm | Target | Price @ Post | Source | Headline |
|---|---|---|---|---|---|---|
| July 14, 2026 11:50 am | — | Truist Financial | $11.00 | $9.67 | TheFly | Aveanna price target raised to $11 from $9 at Truist |
| July 8, 2026 10:19 am | — | Barclays | $9.50 | $9.60 | TheFly | Aveanna price target raised to $9.50 from $9 at Barclays |
| May 20, 2026 11:48 am | David MacDonald | Truist Financial | $9.00 | $7.63 | TheFly | Aveanna price target raised to $9 from $8 at Truist |
| May 18, 2026 9:39 am | — | Barclays | $9.00 | $7.72 | TheFly | Aveanna price target lowered to $9 from $9.50 at Barclays |
| May 15, 2026 10:03 am | — | Stephens | $11.00 | $7.44 | TheFly | Aveanna upgraded to Overweight from Equal Weight at Stephens |
| March 12, 2026 6:55 pm | David MacDonald | Truist Financial | $10.00 | $7.00 | StreetInsider | Truist Securities Reiterates Hold Rating on Aveanna Healthcare Holdings Inc (AVAH) amid acquisition |
| January 16, 2026 10:58 am | — | Barclays | $11.00 | $9.76 | TheFly | Aveanna price target raised to $11 from $9 at Barclays |
| January 15, 2026 1:31 pm | — | RBC Capital | $11.00 | $9.39 | TheFly | Aveanna price target raised to $11 from $10 at RBC Capital |
| January 15, 2026 1:11 pm | — | UBS | $10.00 | $9.37 | TheFly | Aveanna price target raised to $10 from $9.50 at UBS |
| December 5, 2025 11:06 am | John Ransom | Raymond James | $13.00 | $9.14 | StreetInsider | Aveanna Healthcare Holdings Inc (AVAH) PT Raised to $13 at Raymond James |
This site can’t be displayed in an embedded view
Some publishers block loading inside other sites for security reasons. You can open the article in a new tab instead.
Latest News for AVAH

That split has sent investors hunting through smaller names for value the mega caps stopped offering months ago. James Early, who runs research at Curia Financial and models his stock-picking on Warren Buffett's approach to durable, cash-generating businesses, laid out three small-cap stocks trading under $10 a share, each profitable and built on fundamentals rather than hype.

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.

Aveanna Healthcare, ArcBest and Ternium stand out as low-PEG GARP picks, pairing discounted valuations with strong growth metrics.

Here is how Aveanna Healthcare (AVAH) and Align Technology (ALGN) have performed compared to their sector so far this year.

U.S.-Iran tensions likely to lift demand for defensive plays, with Tenet Healthcare, Elevance Health and Aveanna Healthcare standing out as cheap medical stocks.
🧮 Earnings Move Analyzer
Insider Trading
Insider Trading
| Name | Role | Date | Type | Shares | Price | Form | Link |
|---|
Senate Trading
No Senate trades found for AVAH.
U.S. House Trading
No House trades found for AVAH.
Options Chain Settings
Changes apply instantly as you toggle. Tap Done when finished.
Options Chain
Select an expiration to expand. Bid/Ask are shown first (before Mark) on both sides.
